CP and COVID-19: Among these clinical implications, while the presence of binding antibodies is important for seroprevalence studies to distinguish previous infections, the detection and quantification of neutralizing antibodies are crucial for several indications, including the preparation of CP therapy, assessment of neutralizing antibodies in COVID-19 patients, and evaluation of protective immunity.